the right eye, becoming a dull, constant ache, and radiating to the orbit and upper face. The pain worsened in the upright position, and did not improve with topical dexamethasone.
Five months after the vehicle accident, the patient presented to our clinic. Ocular movements were normal. Ophthalmoscopic examination revealed corneal edema, episcleral injection, and rubeosis iridis (abnormal neovascularization in the surface of the iris) in the right eye (figure 1A). A right Marcus-Gunn pupil was present. Visual acuity examination was 20/20 in the left eye, but he was only able to count fingers with the right eye. Funduscopy revealed small hemorrhages in the right retina (figure 1B). IOP was increased in the right eye (24 mm Hg) and normal in the left eye (18 mm Hg). The rest of the neurologic examination was unremarkable.
Complete blood count and coagulation tests were normal. Duplex carotid ultrasonography revealed occlusion of the initial portion of the right common carotid artery. Peak systolic velocity of the left internal carotid artery was increased (146 cm/s). Right ophthalmic artery flow was reversed and increased (125 cm/s). Transcranial Doppler ultrasound showed a reversed flow in the A1 segment of the right anterior cerebral artery. Right middle cerebral artery flow did not change with Valsalva maneuver. A brain magnetic resonance angiography confirmed the occlusion of the right common carotid artery, showing no other abnormalities. As the carotid occlusion did not fully explain the eye pain and visual loss, and to rule out other causes (i.e., arteriovenous malformations or fistulas), an arterial angiography was performed, which verified the presence of occlusion (figure 2A) and revealed an increased collateral vascularization in the right periocular region (figure 2B); thus the diagnosis of OIS was made. He was prescribed treatment with subcutaneous enoxaparin 120 mg/day, and oral prednisone 30 mg/day with dose reduction by 10 mg per week. He later underwent panretinal photocoagulation. By 6 months, the pain had resolved, and the vision loss remained stable. IOP had improved in the right eye (20 mm Hg) and remained unchanged in the left eye (18 mm Hg). Anticoagulant treatment was then switched to aspirin 100 mg/day. DISCUSSION OIS is a potentially blinding and underdiagnosed disorder that arises in the context of chronic arterial hypoperfusion of the eye. 1 OIS most frequently results from hemodynamically significant internal carotid artery occlusion, as the ophthalmic artery is the first branch of the carotid artery and the main arterial source of the eye. 2 Failure to recognize and appropriately treat OIS can result in serious consequences, as the 5-year mortality rate for patients with OIS is 40%, mainly due to stroke or myocardial infarction. 3 OIS 3 Patients with OIS typically present with eye pain and decreased visual acuity. Although most patients complain of gradual vision loss, sudden blindness or amaurosis fugax, particularly lightinduced amaurosis, can also occur. 4, 5 Ophthalmoscopic findings, including conjunctival hyperemia, retinal hemorrhages, neovascular glaucoma, and macular edema, are consequences of the ocular hypoperfusion. 6 Although OIS only develops when the internal carotid stenosis is 90% or greater, almost 5% of patients with stenosis will develop OIS at some point in their lifetime. 7 The pathophysiology of OIS is related to the internal carotid artery stenosis and hypoperfusion of the ocular structures, which results in the emergence of collateral neovascularization.
There is no standarized treatment for OIS. Recognition of the underlying cause (i.e., occlusion of the carotid artery) is the chief step. When feasible, carotid endarterectomy or carotid stenting can be performed, but only if the obstruction is less than 99%. 8, 9 For total carotid occlusion, including patients with carotid dissection, antiplatelet or anticoagulation treatment is favored. Carotid revascularization is not recommended for patients with chronic total carotid occlusion. 8, 9 Chronic retinal and choroidal circulatory impairments in OIS may require treatment with panphotocoagulation to prevent neovascularization. Other therapies, including bevacizumab for neovascular glaucoma, 4 and calcium-channels blockers to prevent vasospasm, 10 may be useful in selected patients.
In this case, the onset of OIS and the neck trauma were temporally related. Hence, we hypothesize that a right carotid dissection, in a patient with previous vascular risk factors, may have produced the occlusion of the internal carotid artery. The internal carotid occlusion contributed to the genesis of collateral branches arising from the external carotid artery. The decrease of the ophthalmic blood flow led to retinal hypoxia, neovascular glaucoma, eye pain, and, finally, visual loss.
OIS represents a diagnostic challenge and should be considered in all patients with rapid unilateral vision loss and ocular pain.
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